Board of Directors

“With the vast knowledge, experience and expertise this new board brings to NCPIC, we are perfectly poised to make Northern California the hub of molecular imaging excellence,” 


- Ruth Tesar, Chief Executive Officer of NCPIC



Cary Adams is currently CEO of the MedForce Accelerator LLC, and Managing Partner at Almond Tree Capital, in Davis, investing in and helping to accelerate early-stage medical technology companies. He is also Chairman of the Board of NexGen Medical Systems, Inc. an early stage life science company commercializing the XCOIL platform of thrombectomy tools. He has over three decades of legal experience representing health systems and other clients in the healthcare industry, practicing law with major law firms in D.C. and California.  Mr. Adams was also the founding president of the Sacramento Angels. He is the founder and Chair Emeritus of Sacramento's Med Start Program, a med tech economic development effort in the Sacramento Davis region. Mr. Adams is a graduate of the University of Virginia (BA) and the University of Maryland School of Law (JD), where he was Editor-in-Chief of the Maryland Law Review.


Patrick R. Brady is Chief Executive Officer of Sutter Roseville Medical Center. He has been involved with Sutter since 1981, and has been in his current position since January 1999. Prior to assuming his current duties, Mr. Brady served as the Chief Executive Officer of Sutter Solano Medical Center (SSMC) for approximately six and a half years.


Prior to SSMC, he served in a variety of executive level positions with Sutter Health in the greater Sacramento Area and in hospital management in Los Angeles, California and Tucson, Arizona. Mr. Brady has a Bachelor of Science degree in Public Administration from the University of Arizona, and a Masters degree in Hospital Administration from the University of Minnesota. His professional activities include leadership roles in the American Hospital Association, American College of Healthcare Executives, California Hospital Association, The Hospital Council of Northern and Central California, and the American Heart Association. He has participated actively in local and regional affairs through Chamber of Commerce Boards, the Board of the Partnership HealthPlan of California, the Board of the Solano Coalition for Better Health, the Board for the Child Abuse Prevention Council for Placer County, the Board for Northern California P.E.T. Imaging, the Placer County Community Advisory Board, Rotary Club of Roseville.  Mr. Brady currently serves as a Board Member of the First Northern Bank of Dixon and as a Board Member of Sierra Forever Families.


Simon Cherry, Ph.D., is a Distinguished Professor in the Departments of Biomedical Engineering and Radiology at UC Davis.  Trained in physics and medical physics, his research has focused on developing new technologies and methods for molecular imaging.  He was responsible for the early development and application of high resolution systems for positron emission tomography (PET), in particular the invention of the microPET technology that was subsequently widely adopted in academia and industry. He developed the first hybrid PET/MRI (magnetic resonance imaging) systems, a technology that has now been translated for clinical use.  More recently, he developed a number of approaches to utilize Cerenkov luminescence that is produced by radionuclides for applications in imaging and therapy.  He currently co-leads the EXPLORER project which aims to develop the world’s first total-body PET scanner.  The technologies developed by his laboratory have been broadly applied in biomedical science to study diseases processes and measure the effects of therapeutic interventions.   Dr. Cherry is a Member of the National Academy of Engineering and the National Academy of Inventors.  He has authored more than 250 peer-reviewed articles, review articles and book chapters in the field of biomedical imaging. He is also lead author of the widely-used textbook "Physics in Nuclear Medicine".


Nathaniel "Sandy" Paige is Managing Principal of Seabright Fund, a private equity search fund based in Davis, CA. Until recently, he was a senior leader at The Jackson Laboratory as Director of International Distribution where he focused on expanding global relationships and distribution for JAX Mice & Clinical Research Services. Mr. Paige has been intimately involved with the growth and management of JAX West in various roles including Site Director and Director of Business Development / Strategic Accounts. Prior to joining JAX, Mr. Paige was General Manager of a 24/7/365 construction products manufacturing plant with Knight-Celotex and VP of Administration of Neptune RTS. Mr. Paige received a B.A. from Middlebury College in Vermont and an M.B.A. from Babson College in Massachusetts.